Treatment of these models with SIRT1 activators such as resveratrol and SRT2104 significantly alleviated depressive symptoms, further supporting a potential role for SIRT1 in the development and treatment of PPD [89,90]. Here, SIRT1 is linked to progressive pseudorheumatoid arthropathy of childhood.